Holman RR, Bethel MA, Mentz RJ, et al
In less than a decade, the field has progressed from single-receptor compounds (semaglutide) to dual-receptor compounds (tirzepatide) to the first triple-receptor agonist retatrutide currently in advanced clinical trials
In late 2023, lawyers filed a motion to consolidate similar Ozempic lawsuits into one mass legal action
Twenty years ago, GLP-1 agonists were niche diabetes drugs
Frequently Asked Questions Research References Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency (J Mol Endocrinol, 1992) Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogs (Growth Regul, 1993) Effects of insulin and LongR3 on serum-free Chinese hamster ovary cell cultures expressing two recombinant proteins (Biotechnol Prog, 2000) IGF-1 LR3 1mg 37.99
E.Diallo-KrouE.GrachtchoukV.YuJ.ColbyL